FDA Approves FEXOFENADINE HYDROCHLORIDE — Aurohealth LLC

**Aurohealth LLC received FDA approval on May 23 for its ANDA 213466 for FEXOFENADINE HYDROCHLORIDE Oral, introducing an additional generic alternative to the widely subscribed antihistamine.** This approval intensifies market competition within the rapidly price-sensitive allergy segment, likely pressuring current branded players through the introduction of accessible, interchangeable formulations.